2011年

November 8, 2011: Kyorin Pharmaceutical and Daiichi Sankyo Brasil Reach Agreement in Brazil for Activities Related to the Development and Marketing of Imidafenacin
November 8, 2011: Summary of Consolidated Financial Results (For the Second Quarter Ended september 30,2011)［Japanese Standard］
November 8, 2011: Consolidated Financial Results (For the Second Quarter Ended september 30,2011)- Supplementary Information
August 22, 2011: First Quarter Consolidated Financial Results for the Fiscal Year Ending March 31, 2012
August 11, 2011: Summary of Consolidated Financial Results(For the First Quarter Ended June 30, 2011)
May 11, 2011: Financial Results for the Fiscal 2010, the Year Ended March 31, 2011- Supplementary Information
May 11, 2011: Summary of Consolidated Financial Results(For the fiscal year ended March 31, 2011)
April 5, 2011: Release of "Uritos® OD Tablets 0.1mg" a Drug for Overactive Bladder
February 24, 2011: Kyorin signed a License Agreement with Almirall on COPD Therapeutic Agent "Aclidinium Bromide" for Japan Territory
February 21, 2011: KYORIN Group's Participation in Environmental Hygiene
February 15, 2011: Third Quarter Consolidated Financial Results for the Fiscal Year Ending March 31, 2011
February 8, 2011: Summary of Consolidated Financial Results (For the Third Quarter Ended December 31, 2010) [Japanese Standard]